Cholinesterase inhibitory, anti-amyloidogenic and neuroprotective effect of the medicinal plant Grewia tiliaefolia – An in vitro and in silico study

References

• Abbasi E, Nassiri-Asl M, Sheikhi M, Shafiee M. 2013. Effects of vitexin on scopolamine-induced memory impairment in rats. Chin J Physiol. 56:184–189.
   PubMed Web of Science ®Google Scholar
• Ashani Y, Peggins JO 3rd, Doctor BP. 1992. Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun. 184:719–726.
   PubMed Web of Science ®Google Scholar
• Badami S, Vijayan P, Mathew N, Chandrashekhar R, Godavarthi A, Dhanaraj SA, Suresh B. 2003. In vitro cytotoxic properties of Grewia tiliaefolia bark and lupeol. Indian J Pharmacol. 35:250–251.
   Google Scholar
• Benzie IF, Strain JJ. 1996. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 239:70–76.
   PubMed Web of Science ®Google Scholar
• Blois MS. 1958. Antioxidant determinations by the use of a stable free radical. Nature. 181:1199–1200.
   Web of Science ®Google Scholar
• Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R. 322 Study Group. 2004. Efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a global, multinational, clinical experience study. Drugs Aging. 21:43–53.
   PubMed Web of Science ®Google Scholar
• Brimson JM, Brimson SJ, Brimson CA, Rakkhitawatthana V, Tencomnao T. 2012. Rhinacanthus nasutus extracts prevent glutamate and amyloid-β neurotoxicity in HT-22 mouse hippocampal cells: possible active compounds include lupeol, stigmasterol and β-sitosterol. Int J Mol Sci. 13:5074–5097.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Lauderback CM. 2002. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med. 32:1050–1060.
   PubMed Web of Science ®Google Scholar
• Chanda S, Dave R. 2009. In vitro models for antioxidant activity evaluation and some medicinal plants possessing antioxidant properties: an overview. Afr J Microbiol Res. 3:981–996.
   Web of Science ®Google Scholar
• Clementi ME, Marini S, Coletta M, Orsini F, Giardina B, Misiti F. 2005. Abeta31–35 and Abeta25–35 fragments of amyloid beta-protein induce cellular death through apoptotic signals: role of the redox state of methionine-35. FEBS Lett. 579:2913–2918.
   PubMed Web of Science ®Google Scholar
• Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM. 2013. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 11:315–335.
   PubMed Web of Science ®Google Scholar
• Corey-Bloom J, Anand R, Veach J. 1998. A randomized trial evaluating the efficacy and safety of ENA 713 rivastigmine tartrate, a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer’s disease. Int J Ger Psychopharmacol. 1:55–65.
   Google Scholar
• Coyle J, Kershaw P. 2001. Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. Biol Psychiatry. 49:289–299.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney D, Andres V, Feathersto RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
   PubMed Web of Science ®Google Scholar
• Estévez AG, Jordán J. 2002. Nitric oxide and superoxide, a deadly cocktail. Ann N Y Acad Sci. 962:207–211.
   PubMed Web of Science ®Google Scholar
• Garrat DC. 1964. The quantitative analysis of drugs, vol. 3. Japan: Chapman and Hall Ltd; p. 456–458.
   Google Scholar
• Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ, Funkenstein HH, Evans DA. 1995. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 273:1354–1359.
   PubMed Web of Science ®Google Scholar
• Herraiz T, Chaparro C. 2006. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. Life Sci. 78:795–802.
   PubMed Web of Science ®Google Scholar
• Hiwale S. 2015. Sustainable horticulture in semiarid drylands. 1st ed. India: Springer (India) Pvt. Ltd; p. 153.
   Google Scholar
• Kandale VV, Mujawar SN, Welasly PJ, Nimbalkar JM. 2013. Development of integrated database of neurodegenerative diseases (IDND). Rev Res. 2:1–5.
   Google Scholar
• Khadeer-Ahamed MB, Krishna V, Dandin CJ. 2010. In vitro antioxidant and in vivo prophylactic effects of two gamma-lactones isolated from Grewia tiliaefolia against hepatotoxicity in carbon tetrachloride intoxicated rats. Eur J Pharmacol. 631:42–52.
   PubMed Web of Science ®Google Scholar
• Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. 1994. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA. 271:985–991.
   PubMed Web of Science ®Google Scholar
• Malinski T. 2007. Nitric oxide and nitroxidative stress in Alzheimer's disease. J Alzheimers Dis. 11:207–218.
   PubMed Web of Science ®Google Scholar
• Matrone C, Brattico E. 2015. The power of music on Alzheimer’s disease and the need to understand the underlying molecular mechanisms. J Alzheimers Dis Parkinsonism. 5:196. doi: 10.4172/2161-0460.1000196.
   Google Scholar
• Mintzer JE, Kershaw P. 2003. The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure. Int J Geriatr Psychiatry. 18:292–297.
   PubMed Web of Science ®Google Scholar
• Mohan V, Gibbs AC, Cummings MD, Jaeger EP, DesJarlais RL. 2005. Docking: successes and challenges. Curr Pharm Des. 11:323–333.
   PubMed Web of Science ®Google Scholar
• Mohandas E, Rajmohan V, Raghunath B. 2009. Neurobiology of Alzheimer's disease. Indian J Psychiatry. 51:55–61.
   PubMedGoogle Scholar
• Oyaizu M. 1986. Studies on product of browning reaction prepared from glucose amine. Jpn J Nutr. 44:307–315.
   Web of Science ®Google Scholar
• Patil MV, Patil DA. 2006. Ethnobotany of Nasik District Maharashtra. New Delhi: Daya Publishing House; p. 183–184
   Google Scholar
• Prasansuklab A, Tencomnao T. 2013. Amyloidosis in Alzheimer's disease: the toxicity of amyloid beta (A β), mechanisms of its accumulation and implications of medicinal plants for therapy. Evid Based Complement Alternat Med. 2013:413808. doi: 10.1155/2013/413808.
   PubMed Web of Science ®Google Scholar
• Sayer R, Law E, Connelly PJ, Breen KC. 2004. Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors. Clin Biochem. 37:98–104.
   PubMed Web of Science ®Google Scholar
• Schneider LS, Mangialasche F, Andreasen N, Feldman H, Giacobini E, Jones R, Mantua V, Mecocci P, Pani L, Winblad B, et al. 2014. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med. 275:251–283.
   PubMed Web of Science ®Google Scholar
• Selvam TN, Vengatakrishnan V, Murugesan S, Damodar SK. 2010. Antioxidant and antiproliferative activity of methanolic extract of Grewia tiliaefolia (Vahl) bark in different cancer cell lines. IJPLS. 1:54–60.
   Google Scholar
• Shanmugam G, Jayakumar R. 2004. Structural analysis of amyloid beta peptide fragment (25–35) in different microenvironments. Biopolymers. 76:421–434.
   PubMed Web of Science ®Google Scholar
• Shaw KP, Aracava Y, Akaike A, Daly JW, Rickett DL, Albuquerque EX. 1985. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol Pharmacol. 28:527–538.
   PubMed Web of Science ®Google Scholar
• Singleton VL, Rossi JA. 1965. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic. 16:144–158.
   Google Scholar
• Suganthy N, Devi KP. 2016. Protective effect of catechin rich extract of Rhizophora mucronata against β-amyloid-induced toxicity in PC12 cells. J Appl Biomed. 14:127–146.
   Web of Science ®Google Scholar
• Syad AN, Devi KP. 2015. Assessment of anti-amyloidogenic activity of marine red alga G. acerosa against Alzheimer's beta-amyloid peptide 25–35. Neurol Res. 37:14–22.
   PubMed Web of Science ®Google Scholar
• Ullah W, Uddin G, Siddiqui BS. 2012. Ethnic uses, pharmacological and phytochemical profile of genus Grewia. J Asian Nat Prod Res. 14:186–195.
   PubMed Web of Science ®Google Scholar
• Uzar E, Alp H, Cevik MU, Fırat U, Evliyaoglu O, Tufek A, Altun Y. 2012. Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci. 33:567–574.
   PubMed Web of Science ®Google Scholar
• Verhoeff NP. 2005. Acetylcholinergic neurotransmission and the beta-amyloid cascade: implications for Alzheimer's disease. Expert Rev Neurother. 5:277–284.
   PubMed Web of Science ®Google Scholar
• World Alzheimer’s Report 2015 – The global impact of dementia – an analysis of prevalence, incidence, cost and trends. October 2015.
   Google Scholar